Terry Roemer

Prokaryotics, Inc.

NIH Rank #5609
  • R01 Holder
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$1.9M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#5,609
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $1.9M across 3 grants · National rank #5609.

Top grants by award amount

Terry Roemer's NIH grant portfolio, ranked by award amount.

  • 5R44AI136213-06R44
    Development of a PO-administered beta-lactam-tarocin combination agent to treat methicillin susceptible and methicillin resistant Staphylococci
    $974.6K
    award amount
  • 5R01AI165740-02R01
    Development of a mechanistically novel Gram-negative antibiotic targeting MsbA-mediated Lipopolysaccharide Biogenesis
    $679.3K
    award amount
  • 5R42AI179344-02R42
    Development of a novel broad spectrum antifungal therapeutic targeting Glycosylphosphatidylinositol (GPI) biosynthesis and cell wall biogenesis
    $295.6K
    award amount

Affiliation

Institutions that have administered grants for Terry Roemer.

Affiliated with Prokaryotics, Inc. (NJ).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Prokaryotics, Inc.
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    Entered Top 50% Nationally
    Ranked #5609